Pre-conception care of diabetes, congenital malformations, and spontaneous abortions

Diabetes Care

Volumn 19, Issue 5, 1996, Pages 514-541

  Kitzmiller, John L ^a   Buchanan, Thomas A ^b   Kjos, Siri ^b   Combs, C Andrew ^a   Ratner, Robert E ^c  

^a Good Samaritan Hospital San Jose   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Medlantic Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL MALFORMATION; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; HIGH RISK PREGNANCY; PATIENT COUNSELING; PATIENT EDUCATION; PRENATAL CARE; PREVALENCE; REVIEW; RISK ASSESSMENT; SPONTANEOUS ABORTION; TERATOGENESIS;

EID: 0029863633     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.5.514     Document Type: Review

References (327)

1. Gabbe SG: Congenital malformations in infants of diabetic mothers. Obstet Gynecol Surv 32 125-132, 1977
2. Mills JL: Malformations in infants of diabetic mothers Teratology 25:385-394 1972
3. Cousins L: Congenital anomalies among infants of diabetic mothers. Am J Obstet Gynecol 147:333-338, 1983
4. Reece EA, Hobbins JC: Diabetic embryopathy: Pathogenesis, prenatal diagnosis and prevention. Obstet Gynecol Surv 41: 325-335, 1986
5. Division of Diabetes Control, Centers for Disease Control: Public health guidelines for enhancing diabetes control through maternal and child health programs MMWR 35:201-207, 1986
6. Jovanovic-Peterson L, Abrams RS, Coustan DR, Cowett RM, Jomsay D, Miller EH, Papatheodorou NH, Patterson AM: Prepregnancy counseling and management of women with pre-existing diabetes or previous gestational diabetes. In Medical Management of Pregnancy Complicated by Diabetes Jovanovic-Peterson L, Ed. American Diabetes Association, Alexandria, VA, 1993, p 3-12
7. America Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement) Diabetes Care 18 (Suppl. 1):8-15, 1995
8. American Diabetes Association: Preconception care of women with diabetes (Position Statement) Diabetes Care 19 (Suppl. 1):S25-S28, 1996
9. White P: Pregnancy complicating diabetes. J Med 7:609-616, 1949
10. Pedersen J: Fetal mortality in diabetics in relation to management during the latter part of pregnancy. Acta Endocrinol 15:282-294, 1954
11. Oakley WG: Prognosis in diabetic pregnancy Br Med J 1:1403-1415, 1953
12. Peel J: A historical review of diabetes and pregnancy. J Obstet Gynaecol Br Commonw 79:385-395, 1972
13. Neave C: Congenital malformation in offspring of diabetics. Perspect Pediatr Pathol 8:213-222, 1984
14. Rubin A, Murphy DP: Studies in human reproduction. III. The frequency of congenital malformations in the offspring of non-diabetic and diabetic individuals. J Pediatr 53:579-585, 1958
15. Kucera J: Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7:61-70, 1971
16. Molsted-Pedersen L, Tygstrup I, Pederson J: Congenital malformations in newborn infants of diabetic women. Lancet i 1124-1126, 1964
17. Soler N, Welsh C, Malins J: Congenital malformations in newborn infants of diabetic mothers. Q J Med 178:303-313, 1976
18. Simpson JL, Elias S, Martin AO, Palmer MS, Ogata ES, Radvany RA. Diabetes in pregnancy. Northwestern University senes (1977-1981) I. Prospective study of anomalies in offspring of mothers with diabetes mellitus. Am J Obstet Gynecol 146 263-270, 1983
19. Ballard JL, Holroyde J, Tsang RC, Chan G, Sutherland JM, Knowles HC. High malformation rates and decreased mortality in infants of diabetic mothers managed after the first trimester of pregnancy. Am Obstet Gynecol 148:1111-1118, 1984
20. McCarter RJ, Kessler II, Comstock GW. Is diabetes mellitus a teratogen or a coteratogen? Am J Epidemiol 125 195-205, 1987
21. Hadden DR, Traub AI, Harley JMG: Diabetes-related perinatal mortality and congenital fetal abnormality: a problem of audit. Diabetic Med 5:321-323, 1988
22. Hod M, Merlob P, Friedman S, Rusecki Y, Schoenfeld A, Ovadia J: Prevalence of congenital anomalies and neonatal complications in the offspring of diabetic mothers in Israel. Isr J Med Sci 27:498-502, 1991
23. Farquhar JW: The child of the diabetic woman. Arch Dis Child 34:76-96, 1959
24. Farquhar JW: Prognosis for babies born to diabetic mothers in Edinburgh. Arch Dis Child 44:36-47, 1969
25. Chung CS, Myrianthopoulos NC: Racial and prenatal factors in major congenital malformations. Am J Human Genet 20: 44-49, 1968
26. Molsted-Pedersen L: Pregnancy and diabetes: a survey. Acta Endocrinol 94 (Suppl. 238):13-19, 1980
27. Becerra JE, Khoury MJ, Cordero JF, Erickson JD: Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 85:1-9, 1990
28. Ferencz C, Rubin JD, McCarter RJ, Clark EB: Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology 41 319-326, 1990
29. Khoury MJ, James LM, Erickson JD: On the use of affected controls to address recall bias in case-control studies of birth defects. Teratology 49:273-281, 1994
30. Bower C, Stanley F, Connell AF, Gent CR, Massey MS: Birth defects in the infants of aboriginal and non-aboriginal mothers with diabetes in Western Australia Med J Aust 156:520-524, 1992
31. Ramos-Arroyo MA, Rodriguez-Pinilla E, Cordero JF: Maternal diabetes: The risk for specific birth defects Eur J Epidemiol 8 503-508, 1992
32. Martinez-Frias ML: Epidemiological analysis of outcomes of pregnancy in diabetic mothers, identification of the most characteristic and most frequent congenital anomalies Am J Med Genet 51:108-113, 1994
33. Chung CS, Mynanthopoulos NC Factors affecting risks of congenital malformations. II. Effect of maternal diabetes. Birth Defects Orig Artic Ser 11:23-37, 1975
34. Koller O: Diabetes and pregnancy. Acta Obstet Gynecol Scand 32:80-103, 1953
35. Rubin A: The influence of diabetes mellitus in men upon reproduction Am J Obstet Gynecol 76:25-29, 1958
36. Comess LJ, Bennett PH, Man MB, Burch TA, Miller M: Congenital anomalies and diabetes in the Pima Indians of Arizona. Diabetes 18:471-477, 1969
37. Bennett PH, Webner C, Miller M: Congenital anomalies and the diabetic and prediabetic pregnancy. In Pregnancy Metabolism, Diabetes and the Fetus: Ciba Foundation Symposium 63 (new series). New York, Excerpta Medica, 1979, p. 207-225
38. Henriques CU, Damm P, Tabor A, Goldstein H, Molsted-Pedersen L: Incidence of fetal chromosome abnormalities in insulin-dependent diabetic women. Acta Obstet Gynecol Scand 70:295-297, 1991
39. Mitchell SC, Sellmann AH, Westphal MC, Park J: Etiologic correlates in a study of congenital heart disease in 56,109 births. Am J Cardiol 28:653-657, 1971
40. Lowy C, Beard RW, Goldschmidt J: Congenual malformations in babies of diabetic mothers. Diabetic Med 3:458-462, 1986
41. Towner D, Kjos SL, Leung B, Montoro MM, Xiang A, Mestman JH, Buchanan TA: Congenital malformations in pregnancies complicated by non-insulin-dependent diabetes mellitus: increased risk from poor maternal metabolic control but not from exposure to sulfonylurea drugs. Diabetes Care 18:1446-1451, 1995
42. Miodovnik M, Mimouni F, Dignan PSJ, Berk MA, Ballard JL, Siddiqi TA, Khoury J, Tsang RC: Major malformations in infants of IDDM women, vasculopathy and early first-trimester poor glycemic control. Diabetes Care 11:713-718, 1988
43. Piacquadio K, Hollingsworth DR, Murphy H: Effects of in-utero exposure to oral hypoglycaemic drugs. Lancet 338: 866-869, 1991
44. Hellmuth E, Damm P, Molsted-Pedersen L: Congenital malformations in offspring of diabetic women treated with oral hypoglycaemic agents during embryogenesis. Diabetic Med 11:471-474, 1994
45. Pedersen J, Molsted-Pedersen L: Congenital malformations: the possible role of diabetes care outside pregnancy. In Pregnancy Metabolism, Diabetes and the Fetus: Ciba Foundation Symposium 63 (new series). New York. Excerpta Medica, 1979, p 265-271
46. Baker L, Egler JM, Klein SH, Goldman AS Meticulous control of diabetes during organogenesis prevents congenital lumbosacral defects in rats. Diabetes 30: 955-959, 1981
47. Horu N, Watanabe G, Ingalls TH: Experimental diabetes in pregnant mice: prevention of congenital malformations in offspring by insulin Diabetes 15:194-204, 1966
48. Wickes IG: Fetal defects following insulin coma in early pregnancy. Br Med J 2:1029-1030, 1954
49. Impastato DJ, Gabriel AR, Lardaro HH: Electric and insulin shock therapy during pregnancy. Dis Nerv Syst 25:542-546, 1964
50. Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L, Metzger BE, Holmes LB, Aarons JH, Brown Z, Reed GF, Bieber FR, Van Allen M, Holzman I, Ober C, Peterson CM, Withiam MJ, Duckles A, Mueller-Heubach E, Polk BF, National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis N Engl J Med 318: 671-676, 1988
51. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD: Preconception care of diabetes: Glycemic control prevents excess congenital malformations. JAMA 265:731-736, 1991
52. Kimmerle R, Heinemann L, Delecki A, Berger M. Severe hypoglycemia: incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 15:1034-1037, 1992
53. Steel JM: Personal experience of prepregnancy care in women with insulin-dependent diabetes Aust NZ J Obstet Gynaecol 34:135-139, 1994
54. Rosenn BM, Miodovnik M, Holeberg G, Khoury JC, Siddiqi TA: Hypoglycemia: The price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 85 417-422, 1995
55. Driscoll SG, Benirschke K, Curtis GW: Neonatal deaths among infants of diabetic mothers. Am J Dis Child 100:818-835, 1960
56. Kalter H, Workany J Congenital malformations etiologic factors and their role in prevention N Engl J Med 308: 424-431, 1983
57. Centers for Disease Control. Perinatal mortality and congenital malformations in infants born to women with insulin-dependent diabetes mellitus: United States, Canada, and Europe, 1940-1988 JAMA 264:437-441, 1990
58. Mills JL, Baker L, Goldman AS: Malformations in infants of diabetic mothers occur before the seventh gestational week Diabetes 28:292-293, 1979
59. Opitz JM Blastogenesis and the "primary field" in human development. Birth Defects Orig Artic Ser 29:3-37, 1993
60. Widness JA, Schwartz HC, Thompson D, Kahn CB, Oh W, Schwartz R: Haemoglobin Alc (glycohaemoglobin) in diabetic pregnancy: an indicator of glucose control and fetal size. J Obstet Gynaecol 85:812-817, 1978
61. Ylinen K, Hekali R, Teramo K: Haemoglobin Alc during pregnancy of insulin-dependent diabetics and healthy controls. J Obstet Gynaecol 1:223-228, 1981
62. O'Shaughnessy R, Russ J, Zuspan FP: Glycosylated hemoglobins and diabetes mellitus in pregnancy. Am J Obstet Gynecol 135:783-790, 1979
63. Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL: Elevated maternal hemoglobin Alc in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304:1331-1334 1981
64. Leslie RDG, Pyke DA, John PN, White JM: Hemoglobin Al in diabetic pregnancy Lancet 11:958-959, 1978
65. Reid M, Hadden D, Harley JMG, Halliday HL, McClure BG: Fetal malformations in diabetics with high haemoglobin Alc in early pregnancy. Br Med J 289: 1001, 1984
66. Ylinen K, Aula P, Stenman UH, Kesaniemi-Kuokkanen T, Teramo K: Risk of minor and major fetal malformations in diabetics with high haemoglobin Alc values in early pregnancy. Br Med J 289: 345-346, 1984
67. Key TC, Giuffrida R, Moore TR: Predictive value of early pregnancy glycohemoglobin in the insulin-treated diabetic patient. Am J Obstet Gynecol 156:1096-1100, 1987
68. Stubbs SM, Doddridge MC, John PN, Steel JM, Wright AD: Haemoglobin Al and congenital malformation. Diabetic Med 4:156-159, 1987
69. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS: First-trimester hemoglobin Al and risk for major malformation and spontaneous abortion in diabetic pregnancy Teratology 39:225-231, 1989
70. Lucas MJ, Leveno KJ, Williams ML, Raskin P, Whalley PJ: Early pregnancy glycosylated hemoglobin, seventy of diabetes, and fetal malformations. Am J Obstet Gynecol 161:426-431, 1989
71. Hanson U, Persson B, Thunell S: Relationship between haemoglobin Alc in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 33:100-104, 1990
72. Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA: Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 84:515-520, 1994
73. Rosenn B, Miodovnik M, St. John P, Siddiqi TA, Khoury J, Mimouni F: Minor congenital malformations in infants of insulin-dependent diabetic women: association with prior glycemic control. Obstet Gynecol 76:745-749, 1990
74. Holmes LB, Cann C, Cook C: Examination of infants for both minor and major malformations to evaluate for possible teratogenic exposures. Prog Clin Biol Res 163B:59-63, 1985
75. Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, Aarons JH, Metzger B, Bieber FR, Knopp RH, Holmes LB, Peterson CM, Withiam-Wilson M, Brown Z, Ober C, Harley E, Macpherson TA, Duckies A, Mueller-Heubach E, National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study: Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 319:1617-1623, 1988
76. Bergman M, Newman SA, Seaton TB, Felig P: Diabetic control and fetal malformations N Engl J Med 319:647, 1988
77. Kitzmiller JL, Main EK: Diabetic control and fetal malformations. N Engl J Med 319 647-648, 1988
78. Skyler JS: Diabetic control and fetal malformations. N Engl J Med 319:648, 1988
79. Miller E. Diabetic control and fetal malformations. N Engl J Med 319:648, 1988
80. Mills JL, Metzger BE, Knopp RH, Aarons JH, Jovanovic-Peterson L, Holmes LB, Simpson JL. Diabetic control and fetal malformations N Engl J Med 319:648-649, 1988
81. Baker L, Piddington R: Diabetic embryopathy: a selective review of recent trends. J Diabetic Complications 7:204-212, 1993
82. Miller JF, Williamson E, Glue J, Gordon YB, Grudzinskas JG, Sykes A: Fetal loss after implantation: a prospective study Lancet 11:554-556, 1980
83. Kalter H: Diabetes and spontaneous abortion: a historical review. Obstet Gynecol 156:1243-1253, 1987
84. Jansen RPS: Spontaneous abortion incidence in the treatment of infertility Am J Obstet Gynecol 143:451-473, 1982
85. Warburton D, Fraser FC: Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Am J Hum Genet 16:1-25, 1964
86. Leridon H: Facts and artifacts in the study of intrauterine mortality: a reconsideration from pregnancy histories. Popul Stud 30:319-336, 1976
87. Harlap S, Shiono PH, Rameharan S: A life table of spontaneous abortions and the effects of age, parity, and other variables. In Human Embryonic and Fetal Death. Porter IH, Hook EB, Eds. New York, Academic, 1980, p. 145-158
88. Sutherland HW, Pruchard CW: Increased incidence of spontaneous abortion in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 156:135-138, 1987
89. Wright AD, Nieholson HO, Pollock A, Taylor KG, Betts S: Spontaneous abortion and diabetes mellitus. Postgrad Med J 59:295-298, 1983
90. Miodovnik M, Lavin JP, Knowles HC, Holroyde J, Stys SJ: Spontaneous abortion among insulin-dependent diabetic women. Am J Obstet Gynecol 150:372-376, 1984
91. Miodovnik M, Skillman C, Holroyde JC, Butler JB, Wendel JS, Siddiqi TA: Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulin-dependent diabetic women Am J Obstet Gynecol 153:439-442, 1985
92. Miodovnik M, Mimouni F, Tsang RC, Ammar E, Kaplan L, Siddiqi TA: Glycemic control and spontaneous abortion in insulin-dependent diabetic women. Obstet Gynecol 68:366-369, 1986
93. Miodovnik M, Mimouni F, Siddiqi TA, Tsang RC: Periconceptional metabolic status and risk for spontaneous abortion in insulin-dependent diabetic pregnancies. Am J Perinatol 5:368-373, 1988
94. Endo A: Teratogenesis in diabetic mice treated with alloxan prior to conception. Arch Environ Health 12:492-500, 1966
95. Eriksson UJ, Dahlstrom E, Larsson KS, Hellerstrom C: Increased incidence of congenital malformations in the off-spring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 31:1-6, 1982
96. Eriksson UJ: Importance of genetic predisposition and maternal environment for the occurrence in congenital malformations in offspring of diabetic rats. Teratology 37:365-374, 1988
97. Duechar EM: Embryonic malformations in rats resulting from maternal diabetes: preliminary observations. J Embryol Exp Morphol 41:93-99, 1977
98. Uriu-Hare JY, Stern JS, Reaven GM, Keen CL: The effect of maternal diabetes on trace element status and fetal development in the rat. Diabetes 34:1031-1040, 1985
99. Eriksson UJ, Lewis NJ, Freinkel N: Growth retardation during early organogenesis in embryos of experimentally diabetic rats. Diabetes 33:281-284, 1984
100. Giavani E, Broccia ML, Prati M, Roversi GD, Vismara C: Effects of streptozotocin-induced diabetes on fetal development of the rat. Teratology 34:81-88, 1986
101. Otani H, Tanaka O, Tatewaki R, Naora H, Yoneyama T: Diabetic environment and genetic predisposition as causes of congenital malformations in NOD mouse embryos. Diabetes 40:1245-1250, 1991
102. Eriksson RSM, Thunberg L, Eriksson UJ: Effects of interrupted insulin treatment on fetal outcome of pregnant diabetic rats Diabetes 38:764-772, 1989
103. Diamond MP, Moley KH, Pellicer A, Vaughn WK, Decherney AH: Effects of streptozotocin- and alloxan-induced diabetes mellitus on mouse follicular and early embryo development. J Reprod Fertil 86:1-10, 1989
104. Vercheval M, De Hertogh R, Pampher S, Vanderheyden I, Michiels B, De Bernardi P, De Meyer R: Experimental diabetes impairs rat embryo development during the preimplantation period. Diabetologia 33:187-191, 1990
105. Beebe LFS, Kaye PL: Maternal diabetes and retarded preimplantation development of mice Diabetes 40:457-461, 1991
106. Pampher S, De Hertogh R, Vanderheyden I, Michiels B, Vercheval M. Decreased inner cell mass proportion in blastocysts from diabetic rats. Diabetes 39:471-476, 1990
107. Styrud J, Thunberg L, Nybacka O, Eriksson UJ: Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats. Pediatr Res 37:343-353, 1995
108. Eriksson UJ: Diabetes in pregnancy: retarded fetal growth, congenital malformations and feto-placental concentrations of zinc, copper and manganese in the rat J Nutr 114:477-484, 1984
109. Uriu-Hare JY, Stern JS, Keen CL: Influence of maternal dietary Zn intake on expression of diabetes-induced teratogenicity in rats. Diabetes 38:1282-1290, 1989
110. Giavani E, Broccia ML, Prati M, Roversi GD: Diet composition modifies embryotoxic effects induced by experimental diabetes in rats. Biol Neonate 59:278-286, 1991
111. Buchanan TA, Freinkel N, Schemmer JK: Embryotoxic effects of brief maternal insulin-hypoglycemia during organogenesis in the rat. J Clin Invest 78:643-649, 1986
112. Diamond MP, Herbert-Moley K, Logan J, Pellicer AM, Lavy G, Vaughn WK, DeCherney AH Manifestation of diabetes mellitus on mouse follicular and pre-embryo development: effect of hyperglycemia per se. Metabolism 39:220-224, 1990
113. Diamond MP, Pettway ZY, Logan J, Moley K, Vaughn W, DeCherney AH: Dose-response effects of glucose, insulin, and glucagon on mouse pre-embryo development Metabolism 40:566-570, 1991
114. Ornoy A, Zusman I: Embryotoxic effect of diabetes on pre-implantation embryos. Isr J Med Sci 27:487-492, 1991
115. De Hertogh R, Vanderheyden I, Pampher S, Robin D, Dufrasne E, Delcourt J: Stimulatory and inhibitory effects of glucose and insulin on rat blastocyst development in vitro. Diabetes 40:641-647, 1991
116. Pampher S, Vanderheyden I, Wuu YD, Baufays L, Maillet O, De Hertogh R. Possible role for TNF-alpha in early embryopathy associated with maternal diabetes in the rat. Diabetes 44:531-536, 1995
117. New DAT: Whole embryo culture and the study of mammalian embryos during organogenesis Biol Rev 53:81-122, 1978
118. Sadler TW: Effects of maternal diabetes on early embryogenesis. I. The teratogenic potential of diabetic serum Teratology 21:339-347, 1980
119. Baker L, Piddington R, Goldman A, Egler J, Moehring J: Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusionincultured mouse embryos. Diabetologia 33:593-596, 1990
120. Styrud J, Eriksson UJ: Development of rat embryos in culture media containing different concentrations of normal and diabetic rat serum. Teratology 46:473-483, 1992
121. Rashbass P, Ellington SKL: Development of rat embryos cultured in serum from rats with streptozotocin-induced diabetes. Terarology 37:51-61, 1988
122. Zusman I, Yaffe P, Raz I, Bar-On H, Ornoy A. Effects of human diabetic serum on the in vitro development of early somite rat embryos Teratology 39 85-92, 1989
123. Cockroft DL, Coppola PT: Teratogenic effects of excess glucose in head fold rat embryos in culture Teratology 16 141-146, 1977
124. Sadler TW: Effects of maternal diabetes on early embryogenesis II Hyperglycemia induced exencephaly Teratology 21: 349-356, 1980
125. Freinkel N, Cockroft DL, Lewis NJ, Gorman L, Akazawa S, Phillips LS, Shambaugh GE II: Fuel-mediated teratogenesis during early organogenesis, the effects of increased concentrations of glucose, ketones, or somatomedin inhibitor during rat embryo culture. Am J Clin Nutr 44:986-995, 1986
126. Eriksson UJ, Borg LAH: Diabetes and embryonic malformation: role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419, 1993
127. Horton WE Jr, Sadler TW: Effects of maternal diabetes on early embryogenesis: alterations in morphogenesis produced by the ketone body, B-hydroxybutyrate. Diabetes 32:610-616, 1983
128. Sadler TW, Hunter ES III, Wynn RE, Phillips LS: Evidence for multifactorial origin of diabetes-induced embryopathies. Diabetes, 38:70-74, 1989
129. Sadler TW, Phillips LS, Balkan W, Goldstein S: Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture. Diabetes 35:861-865, 1986
130. Sadler TW, Horton WE: Effects of maternal diabetes on early embryogenesis, the role of insulin and insulin therapy Diabetes 32:1070-1074, 1983
131. Travers JP, Pratten MK, Beck F: Effects of low insulin levels on rat embryonic growth and development Diabetes 38: 773-778, 1989
132. Travers JP, Exell L, Huang B, Town E, Lammiman MJ, Pratten MK, Beck F. Insulin and insulin-like growth factors in embryonic development. Diabetes 41:318-324, 1992
133. Buehanan TA, Denno K, Sipos GF, Sadler TW. Diabetic teratogenesis: evidence for a multifactorial etiology with little contribution from glucose per se. Diabetes 43 656-660, 1994
134. Cockroft DL: Changes with gestational age in the nutritional requirements of post implantation rat embryos in culture. Teratology 38:281-290, 1987
135. Sussman I, Matschinsky FM: Diabetes affects sorbitol and myo-inositol levels of neuroectodermal tissue during embryogenesis in rat. Diabetes, 37:974-981, 1988
136. Hod M, Star S, Passonneau J, Unterman TG, Freinkel N Glucose-induced dysmorphogenesis in the cultured rat conceptus, prevention by supplementation with myo-inositol. Isr J Med Sci 26 541-544, 1990
137. Hashimoto M, Akazawa S, Akazawa M, Akashi M, Yamamoto H, Maeda Y, Yamaguchi Y, Yamasaki H, Tahara D, Nakanishi T, Nagataki S. Effects of hyperglycaemia on sorbitol and myo-mositol contents of cultured embryos: treatment with aldose reductase inhibitor and myo-inositol supplementation Diabetologia 33:597-602, 1990
138. Wetgensberg MJ, Garcia-Palmer FJ, Fremkel N: Uptake of myo-mositol by early-somite rat conceptus. Diabetes 39 575-582, 1990
139. Strieleman PJ, Connors MA, Metzger BE: Phosphomositide metabolism in the developing conceptus: Effects of hyperglycemia and scyllo-inositol in rat embryo culture, Diabetes 41: 1356-1363, 1992
140. Akasru M, Akazawa S, Akazawa M, Trocino R, Hashimoto M, Maeda Y, Yamamoto H, Kawasaki E, Takino H, Yokota A, Nagataki S: Effects of insulin and myoinositol on embryo growth and development during early organogenesisin streptozotocin-induced diabetic rats. Diabetes 40:1574-1579, 1991
141. Baker L, Piddington R, Goldman A, Egler J, Moehring J: Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia 33:593-596, 1990
142. Eriksson UJ, Naeser P, Brolin SE: Increased accumulation of sorbitol in off-spring of manifest diabetic rats. Diabetes 35.1356-1363, 1986
143. Goldman AS, Baker L, Piddington R, Marx B, Herold R, Egler J: Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 82:8227-8231, 1985
144. Pinter E, Reece EA, Leranth CZ, Garcia-Segura M, Hobbins JC, Mahoney MJ, Naftolin F: Arachidomc acid prevents hyperglycemia-associated yolk sac damage and embryopathy. Am J Obstet Cynecol 155:691-702, 1986
145. Goto MP, Goldman AS, Uhing MR: PGE2 prevents anomalies induced by hyperglycemia or diabetic serumin mouse embryos. Diabetes 41:1644-1650, 1992
146. Eriksson UJ Diabetes in pregnancy, effects on post-implantation embryos. Isr J Med Sci 27 478-486, 1991
147. Eriksson UJ, Borg LAH: Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34, 325-331, 1991
148. Yang X, Borg LAH, Eriksson UJ Altered mitochondrial morphology of rat embryos in diabetic pregnancies Anat Rec 241:255-267, 1995
149. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ: A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc Natl Acad Sci USA 87: 9383-9387, 190
150. Hunter ES III, Sadler TW, Wynn RE. A potential mechanism of DL-B-hydroxybutyrate-induced malformations in mouse embryos. Am J Physiol E72-E80, 1987
151. Shum L, Sadler TW: Biochemical basis for D,L,-beta-hydroxybutyrate-induced teratogenesis Teratology 42:553-563, 1990
152. Sadler TW, Hunter ES III: Hypoglycemia: how little is too much for the embryo? Am J Obstet Gynecol 157:190-193, 1987
153. Akazawa S, Akazawa M, Hashimoto M, Yamaguchi Y, Kuriya N, Toyama K, Ueda Y, Nakanishi T, Mori T, Miyake S, Nagataki S: Effects of hypoglycemia on early embryogenesis in rat embryo culture Diabetalogia 30:791-796, 1987
154. Akazawa M, Akazawa S, Hashimoto M, Akashi M, Yamazaki H, Tahara, D, Yamamoto H, Yamaguchi Y, Nakanishi T, Nagataki S. Effects of brief exposure to insulin-induced hypoglycemia during organogenesis in rat embryo culture. Diabetes 38:1573-1578, 1989
155. Ellington SKL: The development of rat embryos cultured in glucose deficient media. Diabetes 3:1372-1378, 1987
156. Hunter ES, Sadler TW: Fuel-mediated teratogenesis: biochemical effects of hypoglycemia during neurulation in mouse embryos in vitro. Am J Physiol 257:E269-E276, 1989
157. Endo A, Ingalls TH: Chromosomal anomalies in embryos of diabetic mice. Arch Environ Health 16:316-325, 1968
158. Yamamoto M, Endo A, Watanabe G, Ingalls TH: Chromosomal aneuploidies and polyploidies in embryos of diabetic mice. Arch Environ Health 22:468-475, 1971
159. Lee AT, Plump A, DeSimon C, Cerami A, Bucala R: A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryos. Diabetes 44:20-24, 1995
160. Trocino RA, Akazawa S, Takino H, Takao Y, Matsumoto K, Maeda Y, Okuno SI, Nagataki S: Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period. Endocrinol 134:869-878, 1994
161. Ellington SKL: In vitro analysis of glucose metabolism and embryonic growth in postimplantation rat embryos Development 100:431-439, 1987
162. Jollie WP Ultrastructural studies of protein transfer across rodent yolk sac. Placenta 7:263-281, 1986
163. Pinter E, Reece EA, Leranth CZ: Yolk sacfailure in embryopathy due to hyperglycemia. ultrastructural analysis of yolk sac differentiation associated with embryology in rat conceptuses under hyperglycemic conditions. Teratology 33: 73-84, 1986
164. Reece EA, Pinter E, Leranth C, Hobbins JC, Mahoney MJ, Naftolin F Yolk sac failure in embryopathy due to hyperglycemia horseradish peroxidase uptake in the assessment of yolk sac function. Obstet Gynecol 74:755-762, 1989
165. Balkan W, Phillips LS, Goldstein S, Sadler TW: Role of the mouse visceral yolk sac in nutrition: inhibition by a somatomedin inhibitor. J Exper Zool 249:36-40, 1989
166. Hunter ES III, Phillips LS, Goldstein S, Sadler TW: Altered visceral yolk sac function produced by a low-molecular-weight somatomedin inhibitor Teratology 43:331-340, 1991
167. Sadler TW: Langman's Medical Embryology. 5th ed. Baltimore, MD, Williams and Wilkins, 1985, p. 39-47
168. Navarrete VN, Pantagua HE, Alger CR, Manzo PB: The significance of metabolic adjustment before a new pregnancy Am J Obstet Gynecol 107:250-253, 1970
169. Molsted-Pedersen L, Pedersen JF: Congenital malformations in diabetic pregnancies. Acta Pediatr Scand 320 (Suppl.): 79-84, 1985
170. Steel JM, Parboosingh J, Cole RA, Duncan JP: Prepregnancy counseling: a logical prelude to the management of the pregnant diabetic woman. Diabetes Care 3:371-373, 1980
171. Steel JM, Johnstone FD, Smith AF, Duncan LJP: Five years' experience of a "prepregnancy" clinic for insulin-dependent diabetics. Br Med J 285 353-356, 1982
172. Steel JM, Johnstone FD, Hepburn DA, Smith AF: Can prepregnancy care of diabetic women reduce the risk of abnormal babies? Br Med J 301:1070-1074, 1990
173. Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glockner E: Prevention of congenital malformations in infants of insulin-dependent diabetic mothers Diabetes Care 6:219-223, 1983
174. Fuhrmann K, Reiher H, Semmler K, Glockner E: The effect of intensified conventional insulin therapy before and during pregnancy on the malformation rate in offspring of diabetic mothers. Exp Clin Endocrinol 83:173-177, 1984
175. Damm P, Molsted-Pedersen L: Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am J Obscet Gynecol 161:1163-1167, 1989
176. Molsted-Pedersen L, Kuhl C: Obstetrical management in diabetic pregnancy: the Copenhagen experience. Diabetologia 29:13-16, 1986
177. Goldman JA, Dicker D, Feldberg D, Yeshaya A, Samuel N, Karp M: Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconcepuonal diabetic control: a comparative study. Am J Obstet Gynecol 155: 293-297, 1986
178. Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA: Pre-conception management of insulin-dependent diabetes: improvement of pregnancy outcome. Obstet Gynecol 77:846-849, 1991
179. Tchobroutsky C, Vray MM, Altman JJ: Risk/benefit ratio of changing late obstetrical strategies in the management of insulin-dependent diabetic pregnancies. Diabete Metab 17:287-294, 1991
180. Willhoite MB, Bennert HW Jr, Palomaki GE, Zaremba MM, Herman WH, Williams JR, Spear NH: The impact of preconception counseling on pregnancy outcomes. Diabetes Care 16:450-455, 1993
181. Fitzsimmons J, Davidson S: Ascertainment bias in diabetic outcome data Am J Obstet Gynecol 163:682, 1990
182. Damm P, Molsted-Pedersen L: Ascertainment bias in diabetic outcome data. Am J Obstet Gynecol 163:682, 1990
183. Dicker D, Feldberg D, Samuel N, Yeshaya A, Karp M, Goldman JA: Spontaneous abortion in patients with insulin-dependent diabetes mellitus, the effect of preconceptional diabetic control. Am J Obstet Gynecol 158:1161-1164, 1988
184. Gregory R, Tattersall RB: Are diabetic pre-pregnancy clinics worthwhile? Lancet 340:656-658, 1992
185. Janz NK, Herman WH, Becker MP, Charron-Prochownik D, Shayna VL, Lesnick TG, Jacober SJ, Fachnie JD, Kruger DF, Sanfield JA, Rosenblatt SI, Lorenz RP Diabetes and pregnancy: factors associated with seeking pre-conception care. Diabetes. Care 18:157-165, 1995
186. Hare JW, White P: Pregnancy in diabetes complicated by vascular disease. Diabetes 26:953-955, 1977
187. Hollingsworth DR, Jones OW, Resnik R: Expanded care in obstetrics for the 1980s, preconception and early post-conception counseling Am J Obstet Gynecol 149:811-814, 1984
188. Steel JM: Prepregnancy counseling and contraception in the insulin-dependent diabetic patient. Clin Obstet Gynecol 28: 553-566, 1985
189. Scheffler RM, Feuchtbaum LB, Phibbs CS: Prevention, the cost-effectiveness of the California Diabetes and Pregnancy Program. Am J Public Health 82:168-175, 1992
190. Cousins L: The California Diabetes and Pregnancy Program: a statewide collaborative programme for the pre-conception and prenatal care of diabetic women. Bailliere's Clin Obstet Gynaecol 5:443-459, 1991
191. California Department of Health Services: Guidelines for Care. Berkeley, CA. California Dept. of Health Services, Maternal Child Health Branch, 1986
192. California Diabetes and Pregnancy Program: Teaching and Learning Guides: Diabetes and Pregnancy Education Program. Berkeley, CA, California Dept. of Health Services, Maternal Child Health Branch, 1986
193. Elixhauser A, Weschler JM, Kitzmiller JL, Marks JS, Bennert HW Jr, Coustan DR, Gabbe SG, Herman WH, Kaufmann RC, Ogata ES, Sepe SJ: Cost-benefit analysis of preconception care of women with established diabetes mellitus. Diabetes Care 16:1146-1157, 1993
194. Elixhauser A, Weschler JM, Kitzmiller JL, Bennert HW Jr, Coustan DR, Gabbe SG, Herman WH, Kaufmann RC, Ogata ES, Marks JS, Sepe SJ: Financial implications of implementing standards of care for diabetes and pregnancy Diabetes Care 15 (Suppl. 1):22-28, 1992
195. Elixhauser A, Kitzmiller JL, Weschler JM: Short-term cost benefits of pre-conception care of diabetes (Letter). Diabetes Care 19:384, 1996
196. DCCT Research Group: The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35:530-545, 1986
197. DCCT Research Group: Diabetes Control and Complications Trial (DCCT). results of the feasibility study. Diabetes Care 10:1-19, 1987
198. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
199. Kaufmann R: Council on Diabetes in Pregnancy, American Diabetes Association 1993. Cited in Elixhauser A et al. Diabetes Care 16:1146-1157, 1993
200. Molsted-Pedersen L, Skouby SO, Damm P: Preconception counseling and contraception after gestational diabetes Diabetes 40 (Suppl 2):147-150, 1991
201. Metzger B: Summary and recommendations of the Third International Workshop Conference on Gestational Diabetes Mellitus. Diabetes 40 (Suppl. 2):197, 1991
202. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA: Predicting future diabetes in Latino women with gestational diabetes. Diabetes 44:586-591, 1995
203. Kaufmann RC, Schleyhahn FT, Huffman DG, Amankwah KS: Gestational diabetes diagnostic criteria: long-term maternal follow-up. Am J Obstet Gynecol 172: 621-625, 1995
204. Grant PT, Oats JN, Beischer NA: The long-term follow-up of women with gestational diabetes. Aust NZJ Obstet Gynaecol 26 17-22, 1986
205. Damm P, Kuhl C, Bertelsen A, Molsted-Pedersen L: Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 167:607-616, 1992
206. Gregory KD, Kjos SL, Peters RK: Cost of non-insulin-dependent diabetes in women with a history of gestational diabetes: implications for prevention. Obstet Gynecol 811:782-786, 1993
207. Coustan DR, Carpenter MD, O'Sullivan PS, Carr SR: Gestational diabetes: predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol 168:1139-1145, 1993
208. Rosenn B, Miodovnik M, Mimoum F, Khoury JC, Siddiqi TA: Patient experience in a diabetic program project improves subsequent pregnancy outcome. Obstet Gynecol 77:87-92, 1991
209. Miodovnik M, Mimoum F, Siddiqi TA, Khoury J, Berk MA: Spontaneous abortions in repeat diabetic pregnancies: a relationship with glycemic control. Obstet Gynecol 75:75-78, 1990
210. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV: Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy N Engl J Med 308:485-491, 1993
211. Kimmerle R, Heinemann L, Delecki A, Berger M Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 15:1034-1037, 1992
212. Raybum W, Piehl E, Jacober S, Schork A, Ploughman L: Severe hypoglycemia during pregnancy: its frequency and predisposing factors in diabetic women. Int J Gynaecol Obstet 24:263-268, 1986
213. Mokan M, Mitrakou A, Veneman T, Ryan C, Korytkowski M, Cryer P, Gerich J: Hypoglycemia unawareness in IDDM. Diabetes Care 17:1397-1403, 1994
214. Cryer PE: Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 43:1378-1389, 1994
215. Fagen C, King JD, Erick M Nutrition management in women with gestational diabetes mellitus: a review by ADA's Diabetes Care and Education Diabetic Practice Group. J Am Dietet Assoc 95 460-466, 1995
216. Parkman HP, Fisher RS: Gastroparesis: diagnostic and therapeutic management. Pract Gastroenterol 17:18-27, 1993
217. Macleod AF, Smith SA, Sonksen PH, Lowy C: The problem of autonomic neuropathy in diabetic pregnancy. Diabetic Med 7:80-82, 1990
218. Lavin JP Jr. Gimmon Z, Miodovnik M, von Meyenfeldt M, Fischer JE Total parenteral nutrition in a pregnant insulin-requiring diabetic. Obstet Gynecol 59: 660-664, 1982
219. Brown CK, Khardaria U: Use of metodopramide, dompendone, and cisapride in the management of diabetic gastroparesis. Clin Pharm 9:357-365, 1990
220. Stancin T, Link DL, Reuter JM: Binge eating and purging in young women with IDDM. Diabetes Care 12:601-603, 1989
221. Steel JM, Young RJ, Lloyd GG, Clarke BF: Clinically apparent eating disorders in young diabetic women: associations with painful neuropathy and other complications. Br Med J 294:859-862, 1987
222. Mogensen CE: The effect of blood pressure intervention on renal function in insulin-dependent diabetes. Diabete Metab 15:343-345, 1989
223. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443-1447, 1987
224. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118:129-138, 1993
225. Kitzmiller JL, Brown ER, Phillippe M, Stark AR, Acker D, Kaldany A, Singh S, Hare J: Diabetic nephropathy and perinatal outcome. Am J Obstet Gynecol 141: 741-752, 1981
226. Reece EA, Coustan DR, Hayslett JP, Holford T, Coulehan J, O'Connor TZ, Hobbins JC: Diabetic nephropathy: pregnancy performance and fetomaternal outcome. Am J Obstet Gynecol 159:56-66, 1988
227. Kimmerle R, Zab RP, Cupisti S, Somville T, Bender R, Pawlowski B, Berger M: Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia 38:227-235, 1995
228. American Diabetes Association: Treatment of hypertension in diabetes (Consensus Statement). Diabetes Care 16:1394-1401, 1993
229. Greene MF, Hare JW, Krache M, Phillippe M, Barss VA, Saltzman DH, Nadel A, Younger MD, Heffner L, Scherl JE: Prematurity among insulin-requiring diabetic gravid women. Am J Obstet Gynecol 161:106-111, 1989
230. Hanssens M, Keirse MJNC, Vankelecom F, Assche FAV: Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 78:128-1335, 1991
231. Magee LA, Conover B, Schick B, Sage S, Cook L, Ranan-Williams L, Koren G: Exposure to calcium channel blockers in human pregnancy a prospective, controlled, multicentre cohort study. Teratology 49:372-376, 1994
232. Sibai BM, Grossman RA, Grossman HG: Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 150 831-835, 1984
233. Soffronoff EC, Kaufmann BM, Connaughton JFF: Intravascular volume determinations and fetal outcome in hypertensive diseases of pregnancy. Am J Obstet Gynecol 127:4-9, 1977
234. Fairlie FM, Sibai BM Hypertensive diseases in pregnancy. In Medicine of the Fetus and Mother. Reece EA, Hobbins JC, Mahoney MJ, Petrie RH, Eds. Philadelphia, Lippincott, 1992, p. 938-939
235. Cunningham GF, Lindheimer MD: Hypertension in pregnancy. N Engl J Med 326:927-932, 1992
236. Cockburn J, Ounsted M, Moar VA, Redman CWG: Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet i:647-51, 1982
237. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC: Microalbumunuria: an early marker of renal involvement in diabetes. Uremia Invest 9:85-95, 1985-1986
238. Mogensen CE, Vestbo E, Logstrup Poulsen P, Christiansen C, Damsgaard EM, Eiskjer H, Froland A, Wurgler Hansen K, Nielsen S, Pedersen MM: Microalbuminuria and potential confounders: a review and some observations on variability of urinary albumin excretion. Diabetes Care 18:572-581, 1995
239. Combs CA, Wheeler BC, Kitzmiller JL: Urinary protein/creatinine ratio before and during pregnancy in women with diabetes mellitus. Am J Obstet Gynecol 165:920-923, 1991
240. Christiansen JS, Gammelgaard J, Tronier B: Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 21:683-688, 1982
241. Wiseman MJ, Saunders AJ, Keen H, Viberti G: Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes N Engl J Med 312:617-621, 1985
242. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T: Effect of improved metabolic control on loss of kidney function in type I (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 34:164-170, 1991
243. Reichard P, Nilsson BY, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
244. Slataper R, Vicknair N, Sadler R, Bakris L: Comparative effects of different antihypertensive treatments on progression of diabetic renal disease Arch Int Med 153:973-980, 1993
245. Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR: Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 324: 78-84, 1991
246. Ogburn PL, Kitzmiller JL, Hare JW: Pregnancy following transplantation in class T diabetes mellitus. JAMA 255: 911-915, 1986
247. Phelps RL, Sakol P, Metzger BE, Jampol LM, Freinkel N: Changes in diabetic retinopathy during pregnancy. Arch Ophthalmol 104:1806-1810, 1986
248. Klein BEK, Moss SE, Klein R: Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 13:34-40, 1990
249. Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L, Knopp RH, Conley M, Rand L, Simpson JL, Holmes LB, Aarons JH: Metabolic control and progression of retinopathy. Diabetes Care 18:631-637, 1995
250. Chen HC, Newsom RSB, Patel V, Cassar J, Mather H, Kohner EM: Retinal blood flow changes during pregnancy in women with diabetes. Invest Ophthalmol Visual Sci 35:3199-3208, 1994
251. DCCT Research Group: The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 113:36-51, 1995
252. Manske CL, Thomas W, Wang Y, Wilson RF: Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 44:617-621, 1993
253. Marcus MD, Wing RR: Eating disorders in patients with diabetes mellitus. Clin Diabetes 8:38-46, 1988
254. Dibble CM, Kochenour NK, Worley RJ, Tyler FH, Swartz M: Effect of pregnancy on diabetic retinopathy. Obstet Gynecol 59:699-704, 1982
255. Moloney JBM, Drury IM: The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 93: 745-756, 1982
256. Price JH, Hadden DR, Archer DB, Harley JMG: Diabetic retinopathy in pregnancy. Br J Obstet Gynaecol 91:11-17, 1984
257. Jovanovic R, Jovanovic L: Obstetric management when normoglycemia is maintained in diabetic pregnant women with vascular compromise. Am J Obstet Gynecol 149:617-623, 1984
258. Grenfell A, Brudenell JM, Doddridge MC, Watkins PJ: Pregnancy in diabetic women who have proteinuria Q J Med 228:379-386, 1986
259. Combs CA, Rosenn B, Kitzmiller JL, Khoury JC, Wheeler BC, Miodovnik M: Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 82:802-807, 1993
260. Gast MJ, Rigg LA: Class H diabetes and pregnancy. Obstet Gynecol 66 5-7S, 1985
261. Reece EA, Egan JFX, Coustan DR. Coronary artery disease in diabetic pregnancies Am J Obstet Gynecol 154:150-151, 1986
262. Pombar X, Strassner HT, Fenner PC: Pregnancy in a woman with class H diabetes mellitus and previous coronary artery bypass graft: a case report and review of the literature. Obstet Gynecol 85: 825-829, 1995
263. Jacobson AM, Hauser ST, Wolfsdorf JI, Houlihan J, Milky JE, Herskowitz RD, Wertlieb D, Watt E: Psychologic predictors of compliance in children with recent onset of diabetes mellitus. J Pediatr 110:805-811, 1987
264. Sullivan B: Adjustment in diabetic adolescent girls: development of the diabetic adjustment scale. Psychosom Med 41: 119-126, 1979
265. Sullivan B: Adjustment in diabetic adolescent girls II. adjustment, self-esteem, and depression. Psychosom Med 41:127-138, 1979
266. Young-Hyman D, Peyrot M, Jacobson A, Schlundt D, Drotar D, DCCT Research Group: Association of psychosocial distress and self-care behavior with glycemic control (Abstract). Diabetes 44 (Suppl 1):96A, 1995
267. Hirsch IB: Implementation of intensive diabetes therapy for IDDM Diabetes Rev 3:288-307, 1975
268. Bolli GB, Gerich JE. The "dawn phenomenon": a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med 310:746-750, 1984
269. Kitzmiller JL, Younger MD, Hare JW, Phillippe M, Vignati L, Fargnoli B, Grause A. Continuous subcutaneous insulin therapy during early pregnancy. Obstet Gynecol 66:606-611, 1985
270. Coustan DR, Reece EA, Sherwin RS, Rudolf MC, Bates SE, Sockin SM, Holford T, Tamborlane WV: A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA 255:631-636, 1986
271. Rizzo T, Metzger BE, Burns WJ, Burns K: Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med 325:911-916, 1991
272. Infante-Rivard C, Fernandez A, Gauthier R, David M, Rivard GE: Fetal loss associated with caffeine intake before and during pregnancy. JAMA 270:2940-2943, 1993
273. Medical Research Council Vitamin Study Research Group Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131-137, 1991
274. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 1832-1835, 1992
275. Werler MM, Shapiro S, Mitchell AA: Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 269:1257-1261, 1993
276. Burk DT, Mirkes PE: Summary of the 1993 Teratology Society Public Affairs Committee Symposium, folic acid prevention of neural tube defects: public policy issues. Teratology 49:239-241, 1994
277. Hollingsworth DR, Ney DM: Caloric restriction in pregnant diabetic women: a review of maternal obesity, glucose, and insulin relationships. J Am Coll Nutr 11: 251-2S8, 1992
278. Jenkins D, Ocana A, Jenkins AL, Wolever T, Vuksan V, Katzman L, Hollands M, Greenberg G, Corey P, Patten R, Wong G, Josse RG: Metabolic advantages of spreading the nutrient load: effects of increased meal frequency in noninsulin-dependent diabetes. Am J Clin Nutr 55:461-467, 1992
279. Reece EA, Coustan DR, Sherwin RS, Tuck S, Bates S, O'Connor T, Tamborlane WV: Does intensive glycemic control in diabetic pregnancies result in normalization of other metabolic fuels? Am J Obstet Gynecol 165:126-130, 1991
280. Reece EA, Homko C, Wiznitzer A: Metabolic changes in diabetic and nondiabetic subjects during pregnancy. Obstet Gynecol Surv 49:64-71, 1994
281. Mishell DR Jr. Contraception. N Engl J Med 320:777-787, 1989
282. Hatcher RA, Trussel J, Stewart F: Contraceptive Technology. 16th ed, New York, Irvington, 1994
283. Porter JB, Jick H, Walker AM Mortality among oral contraceptive users. Obstet Gynecol 70:29-32, 1987
284. Rosenberg L, Palmer JR, Lesko SM, Shapiro S: Oral contraceptive use and the risk of myocardial infarction Am J Epidemiol 131 1009-1016, 1990
285. Wilson ESB, Cruickshank J, McMaster M, Weir RJ: A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types of dosages and progestogen. Br J Obstet Gynaecol 91:1254-1260, 1984
286. Kjos SL. Contraception in diabetic women. Obstet Gynecol Clin North Am 23:243-257, 1996
287. Dorflinger LJ: Relative potency of progestins used in oral contraceptives. Contraception 31:557-570, 1985
288. Bringer J: Norgestimate: a clinical overview of a new progestin. Am J Obstet Gynecol 166:169-177, 1992
289. Kjaer K, Lebech AM, Borggaard B, Refn H, Pedersen LR, Schierup L, Bremmelgaard A: Lipid metabolism and coagulation of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene. Contraception 40:665-673, 1989
290. Gosland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V: The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism N Engl J Med 323:1375-1381, 1990
291. Waine H, Frieden EH, Caplan HI, Cole T: Metabolic effect of enovid in rheumatoid patients. Arthritis Rheum 6:796, 1963
292. Liew DFM, Ng CSA, Yong YM, Ratnam SS: Long-term effects of depo-provera on carbohydrate and lipid metabolism. Contraception 31:51-64, 1985
293. Spellacy W: Carbohydrate metabolism during treatment with estrogen, progestogen and low-dose oral contraceptive preparations on carbohydrate metabolism. Am J Obstet Gynecol 142:732-734, 1982
294. Spellacy WN, Buhi WC, Birk SA: The effect of estrogens on carbohydrate metabolism: glucose, insulin and growth hormone studies on one hundred seventy-one women ingesting premarin, mestranol and ethinyly estradiol for six months AmJ Obstet Gynecol 114:388-392, 1971
295. Perlman JA, Russell-Briefel R, Ezati T, Lieberknecht G. Oral glucose tolerance and the potency of contraceptive progestins J Chron Dis 38:857-864, 1985
296. Kalkhoff RK: Metabolic effects of progesterone. Am J Obstet Gynecol 142: 735-738, 1982
297. Loke DFM, Ng CSA, Samsioe G, Holck S, Ratnam SS: A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism. Contraception 42:535-554, 1990
298. van der Vange N, Kloosterboer HJ, Haspels AA. Effects of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism. Am J Obscet Gynecol 156:918-922, 1987
299. Petersen KR, Skouby SO, Pederson RG: Desogestrel and gestodene in oral contraceptives: 12 months assessment of carbohydrate and lipoprotein metabolism. Obstet Gynecol 78 666-672, 1991
300. Runnebaum B, Grunwald K, Rabe T. The efficacy and tolerability of norgestimate/ ethinyl estradiol (250 μg of norgestimate/35 μg of ethinyl estradiol): results of an open, multicenter study of 59,701 women. Am J Obstet Gynecol 166 1963-1968, 1992
301. Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, Riflund B: Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol N Engl J Med 308: 862-867 1981
302. Kloosterboer HJ, van Wayjen RG, van del Ende A: Comparative effects of monophasic desogestrel plus ethinyl estradiol and triphasic levonorgestrel plus ethinylestradiol on lipid metabolism. Contraception 34:135-144, 1986
303. Percival-Smith RK, Morrison BJ, Sizto R, Abercrombie B The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young women. Contraception 35:179-187, 1987
304. Radberg T, Gustafson A, Skryten A, Kaarlsson K: Oral contraception in diabetic women: diabetes control, serum and high density lipoprotein lipids during low-dose progestogen, combined oestrogen/progestogen and non-hormonal contraception. Acta Endocrinol 98:246-251, 1981
305. Skouby SO, Jensen BM, Kuhl C, Molsted-Pedersen L, Svenstrup B, Nielsen J: Hormonal contraception in diabetic women: acceptability and influence on diabetes control and ovarian function of a nonalkylated estrogen/progestogen compound. Contraception 32:23-32, 1985
306. Skouby SO, Molsted-Pedersen L, Kuhl C, Bennett P: Oral contraceptives in diabetic women. Metabolic effects of four compounds with different estrogen/progestogen profiles. Fertil Steril 46:858-864, 1986
307. Petersen KR, Gevers Leuren JA, Dersjant-Roorden MC, Heimerhorst FM, deBeer R, Neymeyer-Leloux A, Havecs I. Estrogenic effect of gestodene-or-desgestrel-containing oral contraceptives on lipoprotein metabolism. Am J Obstet Gynecol 163:358-362, 1990
308. Kung AW, Ma JT, Wong VC, Li DFH, Ng MMT, Wang CL, Lam KSL, Young RTT, Ma HK: Glucose and lipid metabolism with triphasic oral contraceptives in women with a history of gestational diabetes. Contraception 35:257-269, 1987
309. Petersen KR, Skouby SO, Vedel P, Haaber AB. Hormonal contraception in women with IDDM influence on glycomeiabolic control and lilpoprotein metabolism Diabetes Care 18:800-806, 1995
310. Kjos SL, Shoupe D, Douyan S, Friedman RL, Bernstein GS, Mestman JH, Mishell DR Jr: Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study Am J Obstet Gynecol 163:1822-1827, 1990
311. Peterson KR, Skouby SO, Sidelmann J, Molsted-Pedersen L, Jespersen J: Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol 171:400-405, 1994
312. Petersen KR, Skouby SO, Sidelmann J, Jespersen J: Assessment of endothelial function during oral contraception in women with insulin-dependent diabetes mellitus Metab Clin Exp 43:1379-1383, 1994
313. Steel JM, Duncan LJP: Serious complications of oral contraception in insulin-dependent diabetics. Contraception 17:291-295, 1978
314. Klein BEK, Moss SE, Klein R: Oral contraceptives in women with diabetes. Diabetes Care 13:895-898, 1990
315. Lawless M, Vessey MP: Intrauterine device use by diabetic women. Br J Fam Plann 7:110-111, 1982
316. Skouby SO, Molsted-Pedersen L, Kosonen A: Consequences of intrauterine contraception in diabetic women. Fertil Steril 42 568-572, 1984
317. Kimmerle R, Weiss R, Berger M, Kurz KH Effectiveness, safety and acceptability of a copper intrauterine device (CU Safe 300) in type I diabetic women. Diabetes Care 16:1227-1230, 1993
318. Kjos SL, Ballagh SA, La Cour M, Xiang A, Mishell DR Jr: The copper T380A intrauterine device in women with type II diabetes mellitus. Obstet Gynecol 84:1006-1009, 1994
319. Farley TMM, Rosenberg MJ, Rowe PJ, Chen JH, Meirek O: Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339: 785-788, 1992
320. Fontbonne A, Basdevant A, Faguer B, Thomassin M, Buchsenschutz D: Contraceptive practice in 209 diabetic women regularly attending a specialized diabetes clinic. Diabete Metab 13:411-415, 1987
321. Kjaer K, Hagen C, Sando SH, Eshoj O: Contraception in women with insulin-dependent diabetes mellitus: an epidemiological study. Diabetes Care 11: 1585-1590, 1992
322. St James PJ, Younger MD, Hamilton BD, Waisbren SE: Unplanned pregnancies in young women with diabetes. Diabetes Care 16:1572-1578, 1993
323. Epstein LH, Wing RR: Behavioral contracting in health care. Clin Behav Ther Rev 1 1-22, 1979
324. Nielsen GL, Nielsen PH: Outcome of 328 pregnancies in 205 women with insulin-dependent diabetes mellitus in the county of Northern Jutland from 1976 to 1990. Eur J Obstet Gynecol Reprod Biol 50:33-38, 1993
325. Cnattingius S, Berne C, Nordstrom ML: Pregnancy outcome and infant mortality in diabetic patients in Sweden. Diabetic Med 11:696-700, 1994
326. Weir C, Naha DM, Singer DE: Standards of care for diabetes. Diabetes Care 17: 1514-1522, 1994
327. Kahkone D, Moltich M, Zinman E, Hollander P, Schaefer B, Backlund JY Outcome of pregnancies in the Diabetes Control and Complications Trial (DCCT) (Abstract). Diabetes 44 (Suppl. 1):13A, 1995